| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.6M | -58.8% |
| R&D Expense | $31.5M | -16.3% |
| SG&A Expense | $14.5M | -29.7% |
| Operating Income | -$44.4M | +19.6% |
| Pre-tax Income | -$44.1M | +14.7% |
| Income Tax | $0 | — |
| Net Income | -$44.1M | +14.7% |
| EPS (Basic) | -$1.01 | +23.5% |
| EPS (Diluted) | -$1.01 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.4M | -75.2% |
| Accounts Receivable | $96K | -4.0% |
| Current Assets | $14.8M | -73.3% |
| Total Assets | $18.1M | -69.5% |
| Current Liabilities | $7.6M | -31.2% |
| Stockholders' Equity | $10.5M | -78.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$40.6M | -11.2% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $0 | -100.0% |
| Financing Cash Flow | $29K | -99.9% |
| Free Cash Flow | -$40.6M | -11.2% |
| +23.5% |